<code id='786FE19B13'></code><style id='786FE19B13'></style>
    • <acronym id='786FE19B13'></acronym>
      <center id='786FE19B13'><center id='786FE19B13'><tfoot id='786FE19B13'></tfoot></center><abbr id='786FE19B13'><dir id='786FE19B13'><tfoot id='786FE19B13'></tfoot><noframes id='786FE19B13'>

    • <optgroup id='786FE19B13'><strike id='786FE19B13'><sup id='786FE19B13'></sup></strike><code id='786FE19B13'></code></optgroup>
        1. <b id='786FE19B13'><label id='786FE19B13'><select id='786FE19B13'><dt id='786FE19B13'><span id='786FE19B13'></span></dt></select></label></b><u id='786FE19B13'></u>
          <i id='786FE19B13'><strike id='786FE19B13'><tt id='786FE19B13'><pre id='786FE19B13'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:647
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          How Robert F. Kennedy Jr. distorted vaccine science
          How Robert F. Kennedy Jr. distorted vaccine science

          STAT,APRobertF.KennedyJr.saidTuesdaythathewillheadupapanelonvaccinesafetyforDonaldTrump.Thepresident

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Skip the lead apron during X

          AdobeThinkbacktothelasttimeyouhadanX-ray:Theradiologictechnologistprobablyplacedaleadapronoverpartof